BioPharm Asia, Inc (fka BFAR)

[wallas2g1]

english.jl.gov.cn/News/GeneralNews/201112/t20111206_1114933.html

I think this article is interesting and should maybe enlighten us as investors in this company.

BFAR subsidiary Tongshua Tianbao Cuttivation Company, acquired by Huachen (HERB) another subsidiary of BFAR is in the business of cultivating wood frogs as most of you already know.

If I remember correctly, a forumer questioned how a company could make so much money from cultivating wood frogs? Well it turns out from this article that it's a growing and profitable industry after all with not a whole lot of players.

The PR of December 5 2011 "Preliminary unaudited results from 2011" confirms this increase in profitability and demand for wood frog. All that matters now is validating those numbers and for that, I, like most forumers wait patiently.

My point is it is not unreasonable after all for BFAR to announce increase in profit from woodfrog cultivation.